Neurology

The CGTLive Neurology specialty topic page houses video interviews with key opinion leaders in the field of neurology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to cell therapies, gene therapies, and engineered and regenerative medicines developed for neurologic disorders and diseases. It also contains up-to-date clinical news coverage in the field of gene and cell therapy for central nervous system disorders.

Latest News

Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024
Around the Helix: Cell and Gene Therapy Company Updates – April 24, 2024

April 24th 2024

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

First Patient Treated With Benitec Biopharma’s Oculopharyngeal Muscular Dystrophy Gene Therapy Shows Swallowing Improvements
First Patient Treated With Benitec Biopharma’s Oculopharyngeal Muscular Dystrophy Gene Therapy Shows Swallowing Improvements

April 21st 2024

CGTLive®’s Weekly Rewind – April 19, 2024
CGTLive®’s Weekly Rewind – April 19, 2024

April 19th 2024

Around the Helix: Cell and Gene Therapy Company Updates – April 17, 2024
Around the Helix: Cell and Gene Therapy Company Updates – April 17, 2024

April 17th 2024

Aravindhan Veerapandiyan, MD, a child neurologist and assistant professor at Arkansas Children’s Hospital (ACH), as well as the director of the Comprehensive Neuromuscular Program and codirector of the Muscular Dystrophy Association Care Center at ACH
RGX-202 Is Well-Tolerated At Multiple Doses Among Patients With DMD

April 16th 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.